Fkbp10-KO Mouse
一般名
Fkbp10-KO
製品ID
S-KO-16970
背景情報
C57BL/6JCya
系統ID
KOCMP-14230-Fkbp10-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Fkbp10-KO Mouse（カタログ番号S-KO-16970）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Fkbp10-KO
系統ID
KOCMP-14230-Fkbp10-B6J-VB
遺伝子名
製品ID
S-KO-16970
遺伝子別名
Fkbp6, FKBP65, Fkbprp, FKBP-10, FKBP-65, Fkbp-rs1, Fkbp1-rs
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 11
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000001595
NCBIトランスクリプトID
NM_010221
ターゲット領域
Exon 2~6
有効領域の大きさ
~2.5 kb
遺伝子研究の概要
FKBP10, also known as FK506 binding protein 10, is a peptidyl-prolyl cis-trans isomerase (PPIase) with important functions. It is involved in multiple biological processes, such as protein translation, and is associated with pathways like hypoxia, glycolysis, and PI3K-AKT signaling. Abnormal expression of FKBP10 is related to the development of various cancers and some skeletal diseases, indicating its overall biological importance. Genetic models, including KO/CKO mouse models, are valuable for studying its functions [1-10].
In KO mouse models, deletion of Fkbp10 in osteoblasts led to qualitative defects in bone, with decreased mature, hydroxylysine-aldehyde crosslinking, reduction in mineral-to-matrix ratio and crystal size, and impaired bone biomechanical strength [7]. In disease-related studies, FKBP10 promotes the progression of clear cell renal cell carcinoma, glioma, lung cancer, colorectal cancer, stomach adenocarcinoma, and bladder cancer. In clear cell renal cell carcinoma, it enhances the Warburg effect and histone lactylation by phosphorylating LDHA [1]. In glioma, it activates the AKT-CREB-PCNA axis to promote cell proliferation [2]. In lung cancer, it boosts cancer growth and stemness via its PPIase activity and affects protein translation [3]. In colorectal cancer, circREEP3 activates FKBP10 transcription to drive tumor progression [4]. In stomach adenocarcinoma, it promotes cell proliferation, invasion, and migration by regulating the PI3K signaling pathway [5,6]. In bladder cancer, it promotes muscle invasion by dysregulating lamin A [8].
In conclusion, FKBP10 plays essential roles in protein-related processes and is involved in the development of multiple cancers and skeletal diseases. The study of Fkbp10 KO/CKO mouse models has provided insights into its functions in bone development and the pathogenesis of related diseases, highlighting its potential as a therapeutic target in cancer and other disorders.
References:
1. Liu, Ren, Zou, Zhihao, Chen, Lingwu, Wang, Zongren, Zhong, Weide. 2024. FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. In Cell death & disease, 15, 64. doi:10.1038/s41419-024-06450-x. https://pubmed.ncbi.nlm.nih.gov/38233415/
2. Cai, Hong-Qing, Zhang, Min-Jie, Cheng, Zhi-Jian, Wang, Ming-Rong, Wan, Jing-Hai. 2021. FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis. In Journal of biomedical science, 28, 13. doi:10.1186/s12929-020-00705-3. https://pubmed.ncbi.nlm.nih.gov/33557829/
3. Ramadori, Giorgio, Ioris, Rafael M, Villanyi, Zoltan, Collart, Martine A, Coppari, Roberto. . FKBP10 Regulates Protein Translation to Sustain Lung Cancer Growth. In Cell reports, 30, 3851-3863.e6. doi:10.1016/j.celrep.2020.02.082. https://pubmed.ncbi.nlm.nih.gov/32187554/
4. Chen, Zhenzhen, He, Luyun, Zhao, Liangbo, Zhu, Pingping, Liu, Benyu. 2022. circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9, e2105160. doi:10.1002/advs.202105160. https://pubmed.ncbi.nlm.nih.gov/35233964/
5. Wang, Ruo-Gu, Zhang, Dan, Zhao, Chun-Hong, Qu, Hui, He, Qing-Si. 2019. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma. In The Kaohsiung journal of medical sciences, 36, 311-317. doi:10.1002/kjm2.12174. https://pubmed.ncbi.nlm.nih.gov/31868996/
6. Liang, Liang, Zhao, Kun, Zhu, Jin-Hui, Qin, Xin-Gan, Chen, Jun-Qiang. 2019. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer. In Oncology reports, 42, 615-628. doi:10.3892/or.2019.7195. https://pubmed.ncbi.nlm.nih.gov/31233188/
7. Lietman, Caressa D, Lim, Joohyun, Grafe, Ingo, Krakow, Deborah, Lee, Brendan H. 2017. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone. In Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 32, 1354-1367. doi:10.1002/jbmr.3108. https://pubmed.ncbi.nlm.nih.gov/28206698/
8. Zhao, Xupeng, Wang, Jichen, Tian, Shuo, Li, Xiubin, Li, Hongzhao. 2025. FKBP10 Promotes the Muscle Invasion of Bladder Cancer via Lamin A Dysregulation. In International journal of biological sciences, 21, 758-771. doi:10.7150/ijbs.105265. https://pubmed.ncbi.nlm.nih.gov/39781460/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。